The SURPASS trials monitored thyroid adverse events as a primary safety focus and found no statistically significant increase in thyroid nodule formation or other thyroid complications in tirzepatide-treated groups versus placebo or semaglutide
It makes sense if you just think about it that in the world there's clearly all this artificial light, which is doing damage to us, and yet the color blue in and of itself would not be something bad for us when people are walking through the world as hunter-gatherers
Zhao D, Zarif M, Zhou Q, Capo-Chichi JM, Schuh A, Minden MD, Atenafu EG, Kumar R, Chang H
GLP-1 agonists cause real short-term side effects like nausea, fatigue, headaches, and diarrhea on top of your existing thyroid symptoms
trial-specific protocols will specify this
What nutrients are most important for hair health during weight loss